RCUS Key Financial Ratios - Arcus Biosciences, Inc.

Complete source-backed ratio history.

Historical Key Financial Ratios

Date	Current ratio	Debt/equity	ROA	ROE
2026-06-30	3.82	—	-49.78%	-99.14%
2026-03-31	4.04	—	-37.01%	-70.42%
2025-12-31	4.36	—	-30.99%	-55.94%
2025-09-30	3.65	—	-35.01%	-78.21%
2025-06-30	4.5	—	-27.72%	-54.28%
2025-03-31	5.37	—	-33.82%	-73.63%
2024-12-31	4.5	—	-24.61%	-58.35%
2024-09-30	5.24	—	-21.57%	-47.79%
2024-06-30	5.14	—	-20.99%	-39.21%
2024-03-31	5.22	—	-17.87%	-32.67%
2023-12-31	4.52	—	-28.04%	-66.45%
2023-09-30	4.41	—	-24.60%	-56.35%
2023-06-30	5.48	—	-23.52%	-50.71%
2023-03-31	5.67	—	-22.25%	-46.50%
2022-12-31	5.53	—	-19.85%	-40.64%
2022-09-30	6.21	—	5.71%	11.38%
2022-06-30	7.48	—	4.51%	8.91%
2022-03-31	7.84	—	3.73%	7.23%
2021-12-31	7.6	—	3.33%	6.29%
2021-09-30	3.82	—	-33.19%	-51.33%
2021-06-30	5.72	—	-22.11%	-32.87%
2021-03-31	6.38	—	-17.95%	-25.25%
2020-12-31	6.05	—	-15.93%	-24.50%
2020-09-30	4.89	—	-10.80%	-16.09%
2020-06-30	11.78	—	-23.22%	-26.07%
2020-03-31	7.91	—	-53.82%	-67.40%
2019-12-31	8.49	—	-41.71%	-51.65%
2019-09-30	9.52	—	-37.06%	-45.37%
2019-06-30	8.59	—	-28.82%	-35.02%
2019-03-31	12.89	—	-21.01%	-24.51%
2018-12-31	15.29	—	-18.04%	-21.11%
2018-09-30	15.97	—	-17.62%	-20.61%
2018-06-30	16.33	—	-21.38%	-24.68%
2018-03-31	19.78	—	-19.27%	-22.07%
2017-12-31	13.9	—	-27.87%	73.39%

Date	Current ratio	Debt/equity	ROA	ROE
2025-12-31	4.36	—	-30.99%	-55.94%
2024-12-31	4.5	—	-24.61%	-58.35%
2023-12-31	4.52	—	-28.04%	-66.45%
2022-12-31	5.53	—	-19.85%	-40.64%
2021-12-31	7.6	—	3.33%	6.29%
2020-12-31	6.05	—	-15.93%	-24.50%
2019-12-31	8.49	—	-41.71%	-51.65%
2018-12-31	15.29	—	-18.04%	-21.11%
2017-12-31	13.9	—	-27.87%	73.39%
2016-12-31	—	—	—	89.88%